快速建立并部署由重症监护医师主导的静脉-静脉体外膜氧合插管项目
该研究为单中心回顾性前后对照观察性研究,比较胸心外科医师与重症监护医师在已建立ECMO项目中行经皮VV-ECMO插管的安全性和有效性。两组患者平均BMI无差异,插管前机械通气天数、插管构型、插管尺寸及出院状况均无差异;按插管部位计算的首次尝试成功率(95.5% vs 96.7%,p=0.483)和主要并发症率(4.5% vs 3.5%,p=1)均无差异。结论为在已建立的ECMO项目中,重症监护医师可快速部署VV-ECMO插管项目并达到高成功率、低并发症率。
要点
- 在已建立ECMO项目的成人ICU中,由重症监护医师执行经皮VV-ECMO插管,首次尝试成功率96.7%,与胸心外科医师的95.5%无差异(p=0.483)。
- 按插管部位计算的主要并发症率,重症监护医师组为3.5%,胸心外科医师组为4.5%,两组无差异(p=1)。
- 两组患者平均BMI(33.86 vs 35.89,p=0.775)、插管前机械通气天数、插管构型、插管尺寸及出院状况均无差异。
- 该研究为单中心回顾性前后对照观察性研究,样本量小(共40例患者),结论需前瞻性验证。
适用人群与场景
- 在已建立ECMO项目的三级学术医学中心成人ICU中,因严重呼吸衰竭接受经皮VV-ECMO插管的危重成人患者。
- 原文未提及明确的纳入标准、排除标准或院前/急诊场景。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及具体药物剂量、给药途径、频次或目标值。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 人群:接受经皮VV-ECMO插管的严重呼吸衰竭危重成人;干预:由重症监护医师执行经皮VV-ECMO插管;对照:由胸心外科医师执行经皮VV-ECMO插管。
- 主要终点:按插管部位计算的首次尝试成功率,胸心外科组95.5% vs 重症监护医师组96.7%(p=0.483),无差异。
- 关键次要终点:按插管部位计算的主要并发症率,胸心外科组4.5% vs 重症监护医师组3.5%(p=1),无差异;两组平均BMI(33.86 vs 35.89,p=0.775)、插管前机械通气天数、插管构型、插管尺寸及出院状况均无差异。
- 不良事件:原文仅报告主要并发症率,未列出具体不良事件类型。
证据类型、等级与局限
- 证据类型:单中心回顾性观察性前后对照研究;原文未给出证据等级或推荐强度。
- 局限:单中心、回顾性、样本量小(共40例患者)、前后对照设计而非随机对照,原文未提及盲法或混杂因素控制。
对床旁实践的改变
- 在已建立的ECMO项目中,可考虑由重症监护医师快速部署并执行经皮VV-ECMO插管,本研究显示首次尝试成功率和主要并发症率与胸心外科医师无差异。
- 适用人群为在已建立ECMO项目的成人ICU中因严重呼吸衰竭接受经皮VV-ECMO插管的危重成人;原文未提及其他适用或不适用人群。
- 常见陷阱:本研究为单中心回顾性前后对照设计、样本量小,结论不能外推至尚未建立ECMO项目的中心或非重症监护医师培训体系。
指南或共识出处
- 原文未提及指南或共识出处;文献来源为Crit Care Med。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine the safety and efficacy of a rapidly deployed intensivist-led venovenous extracorporeal membrane oxygenation cannulation program in a preexisting extracorporeal membrane oxygenation program.
DESIGN: A retrospective observational before-and-after study of 40 patients undergoing percutaneous cannulation for venovenous extracorporeal membrane oxygenation in an established cannulation program by cardiothoracic surgeons versus a rapidly deployed medical intensivist cannulation program.
SETTING: An adult ICU in a tertiary academic medical center in Camden, NJ.
PATIENTS: Critically ill adult subjects with severe respiratory failure undergoing percutaneous cannulation for venovenous extracorporeal membrane oxygenation.
INTERVENTIONS: Percutaneous cannulation for venovenous extracorporeal membrane oxygenation performed by cardiothoracic surgeons compared with cannulations performed by medical intensivists.
MEASUREMENTS AND MAIN RESULTS: Venovenous extracorporeal membrane oxygenation cannulation site attempts were retrospectively reviewed. Subject demographics, specialty of physician performing cannulation, type of support, cannulation configuration, cannula size, imaging guidance, success rate, and complications were recorded and summarized. Twenty-two cannulations were performed by three cardiothoracic surgeons in 11 subjects between September 2019 and February 2020. The cannulation program rapidly transitioned to an intensivist-led and performed program in March 2020. Fifty-seven cannulations were performed by eight intensivists in 29 subjects between March 2020 and December 2020. Mean body mass index for subjects did not differ between groups (33.86 vs 35.89; p = 0.775). There was no difference in days on mechanical ventilation prior to cannulation, configuration, cannula size, or discharge condition. There was no difference in success rate of cannulation on first attempt per cannulation site (95.5 vs 96.7; p = 0.483) or major complication rate per cannulation site (4.5 vs 3.5; p = 1).
CONCLUSIONS: There is no difference between success and complication rates of percutaneous venovenous extracorporeal membrane oxygenation canulation when performed by cardiothoracic surgeons versus medical intensivist in an already established extracorporeal membrane oxygenation program. A rapidly deployed cannulation program by intensivists for venovenous extracorporeal membrane oxygenation can be performed with high success and low complication rates.
参考来源
- Kouch M, Green A, Damuth E, et al. Rapid Development and Deployment of an Intensivist-Led Venovenous Extracorporeal Membrane Oxygenation Cannulation Program. Crit Care Med. 2022. PMID: 34637417. doi:10.1097/CCM.0000000000005282
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。